Author:
Hause Anne M.,Moro Pedro L.,Baggs James,Zhang Bicheng,Marquez Paige,Melgar Michael,Britton Amadea,Stroud Erin,Myers Tanya R.,Rakickas Jeffrey,Blanc Phillip G.,Welsh Kerry,Broder Karen R.,Su John R.,Shay David K.
Publisher
Centers for Disease Control MMWR Office
Reference9 articles.
1. Rates of medically attended RSV among US adults: a systematic review and meta-analysis.;McLaughlin;Open Forum Infect Dis,2022
2. Food and Drug Administration. Approval letter: Arexvy. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2023. https://www.fda.gov/media/167806/download
3. Food and Drug Administration. Approval letter: Abrysvo. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2023. https://www.fda.gov/media/168890/download
4. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices—United States, 2023.;Melgar;MMWR Morb Mortal Wkly Rep,2023
5. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).;Shimabukuro;Vaccine,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献